Thursday, September 11, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Maintains Neutral Rating on CNX Resources with Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 1, 2024
in Breaking News
0
Finance_ Chart up
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

On March 1, 2024, analyst Nitin Kumar from Mizuho continues to hold a Neutral rating on CNX Resources (NYSE:CNX) while increasing the price target to $24 from $23. This adjustment is based on Kumar’s assessment of the company’s potential in the energy industry. Even with the higher price target, Kumar maintains a Neutral stance, suggesting a cautious yet optimistic view on CNX Resources’ future growth.

CNX Stock Shows Stability and Strength on March 1, 2024 Despite Slight Dip

On March 1, 2024, CNX stock showed some mixed performances as it traded near the top of its 52-week range and above its 200-day simple moving average. The stock opened at $20.95, inline with its previous close, but experienced a slight decrease of $0.08, representing a 0.38% drop since the market last closed.

Despite the slight dip in price, CNX’s overall performance indicates strength and stability as it continues to trade at higher levels within its range. This suggests that investors have confidence in the company’s prospects and are willing to hold onto their positions.

The fact that CNX is trading above its 200-day simple moving average is a positive sign for the stock, indicating that it is in an uptrend and has the potential for further growth.

Overall, CNX’s performance on March 1, 2024, demonstrates a mix of stability and slight volatility. Investors should continue to monitor the stock’s movements and consider the broader market conditions before making any investment decisions.

CNX Stock Financial Performance Analysis: Revenue Decrease but Impressive Net Income Growth

On March 1, 2024, CNX stock had some interesting performances based on the financial data provided by CNN Money. The total revenue for the company was reported to be $1.50 billion for the past year, a significant decrease of 61.69% compared to the previous year. However, the total revenue remained flat since the last quarter, indicating some stability in the company’s revenue stream.

In terms of net income, CNX reported a net income of $1.72 billion for the past year, which represents an impressive increase of 1311.12% compared to the previous year. Similar to the total revenue, the net income also held flat since the last quarter, suggesting that the company was able to maintain its profitability despite the decrease in revenue.

Earnings per share (EPS) for CNX stock was reported to be $8.96 for the past year, showing a substantial increase of 1295.33% compared to the previous year. Like the total revenue and net income, the EPS held flat since the last quarter, indicating that the company’s earnings were stable over the short term.

Overall, the financial performance of CNX stock on March 1, 2024, showed a mixed picture. Investors may want to closely monitor CNX stock in the coming months to see if the company can sustain its profitability and potentially improve its revenue growth.

Tags: CNX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
MO stock news

RBC Capital Analyst Increases Price Target for General Electric to 170 Maintains Outperform Rating

Analyst Upgrades Sweetgreen Price Target to 19

Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Analyst Upgrades Catalyst Pharmaceuticals to Overweight with New Price Target of 34

Recommended

Empire State Realty Stock

Major Shareholder Trims Stake in Empire State Realty Trust

3 weeks ago
Pliant Therapeutics Inc Stock

Pliant Therapeutics Shares Plummet Following Clinical Trial Setback

4 days ago
Oasis Petroleum Stock

Chord Energy Navigates Production Success and Profitability Concerns

1 week ago
Biotechnology Trading online

Analyst Upgrades UiPath to Sector Perform Rating with Increased Price Target

1 year ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BioNTech Broadcom C Coinbase DIS Eli Lilly Fiserv IBM Intel Iovance Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF MSFT NIO Nvidia Opendoor Oracle Palantir PayPal Red Cat Robinhood Rocket Lab USA SMCI Strategy Tesla Tilray TSLA Unitedhealth Viking Therapeutics
No Result
View All Result

Highlights

MercadoLibre’s Growth Trajectory Faces Profitability Test

QuantumScape’s Milestone Achievement Contrasts With Executive Stock Sales

Defense Contracts Drive Palantir’s Strategic Momentum

Gilead Sciences Charts Growth Through AI Integration and Strategic Expansion

Navigating Present Challenges While Investing in Tomorrow’s Flight Technology

Meta Secures Legal Victory in EU Fee Dispute

Trending

TG Therapeutics Stock
Analysis

A Single Drug Propels TG Therapeutics Into Biotech Contention

by Dieter Jaworski
September 11, 2025
0

Could one therapy transform an underfunded biotech into a market leader? TG Therapeutics is making a compelling...

Marsh McLennan Stock

Marsh McLennan’s Strategic Pivot Amid Stock Market Challenges

September 11, 2025
Realty Income Stock

Realty Income Extends Its Legendary Dividend Streak to 132 Consecutive Increases

September 11, 2025
MercadoLibre Stock

MercadoLibre’s Growth Trajectory Faces Profitability Test

September 11, 2025
QuantumScape Stock

QuantumScape’s Milestone Achievement Contrasts With Executive Stock Sales

September 11, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • A Single Drug Propels TG Therapeutics Into Biotech Contention September 11, 2025
  • Marsh McLennan’s Strategic Pivot Amid Stock Market Challenges September 11, 2025
  • Realty Income Extends Its Legendary Dividend Streak to 132 Consecutive Increases September 11, 2025

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com